Bottom line
Is IYH a good fund? The bottom line
IYH is a managed health care sector ETF from iShares.
Annual fees run 0.37% — about $37 a year on every $10,000 invested, cheaper than 87% of health care sector funds we track.
It returned +13.1% over one year, +7.0% a year over five years, +9.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.6 billion in net assets and 103 holdings, its largest position is Eli Lilly And Company (15.1%) and the top 10 make up 59% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 90% top-holdings overlap).
What stands out
- Low cost: cheaper than 87% of health care sector peers
- 5-year return beat 85% of category peers
What to watch
- Concentrated: top 10 holdings are 59% of assets
Updated Nov 19, 2026
What IYH invests in
The iShares U.S. Healthcare ETF (the Fund ) seeks to track the investment results of an index composed of U.S. equities in the healthcare sector.
The Fund seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index (the Underlying Index ), which measures the performance of the healthcare sector of the U.S. equity market, as defined by FTSE Russell (the Index Provider or Russell ). The Underlying Index may include large- and mid-capitalization companies. The Underlying Index is a subset of the Russell 1000 Index, which is a float-adjusted capitalization-weighted index of equity securities issued by approximately the 1,000 largest issuers in the Russell 3000 Index. The Russell 3000 Index measures the performance of the broad U.S. equity market, as defined by Russell. The Underlying Index uses a capping methodology to constrain at quarterly rebalance: (i) the weight of any single issuer (as determined by Russell) to a maximum of 22.5%, and (ii) the aggregate weight of all issuers that individually…
From the fund's prospectus (filed Aug 21, 2026).
IYH performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IYH | +13.1% | +7.0% | +9.4% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What IYH costs
On a $10,000 investment, IYH's 0.37% expense ratio costs about $37 a year. The prospectus estimates $468 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
IYH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly And Company | 15.11% |
| 2 | Johnson & Johnson | 10.17% |
| 3 | Abbvie Inc. | 7.32% |
| 4 | Unitedhealth Group Incorporated | 6.16% |
| 5 | Merck & Co., Inc. | 5.31% |
| 6 | Thermo Fisher Scientific Incorporated | 3.52% |
| 7 | Amgen Inc. | 3.42% |
| 8 | Abbott Laboratories | 3.02% |
| 9 | Gilead Sciences, Inc. | 2.66% |
| 10 | Pfizer Inc. | 2.35% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 59% of the fund. See all top 25 holdings and asset mix →
Alternatives to IYH
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 90% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 91% | Compare |
| Vanguard | VHT Vanguard Health Care Index Fund | 0.09% | 92% | Compare |
| J.P. Morgan | JDOC JPMorgan Healthcare Leaders ETF | 0.65% | 60% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 76% | Compare |
| T. Rowe Price | PRHSX T. Rowe Price Health Sciences Fund, Inc. | 0.83% | 77% | Compare |